Fertilizers · Founded 1969 · www.ariesagro.com · BSE 532935 · NSE ARIES AGRO · ISIN INE298I01015
No Notes Added Yet
Business
Aries Agro Ltd. is an Indian agri-inputs company primarily engaged in the manufacturing and marketing of micronutrients and specialty fertilizers. Its core business revolves around providing essential nutrients to crops to enhance soil health, crop yield, and quality. The company offers a wide range of products including chelated micronutrients, water-soluble fertilizers, secondary nutrients, plant protection products, and animal nutrition supplements. Aries Agro makes money by selling these value-added agricultural inputs directly to farmers through an extensive dealer and distributor network across India. Their focus is on scientific farming solutions rather than commoditized bulk fertilizers.
Revenue Mix
Aries Agro's primary revenue driver is its Fertilizer segment, specifically focused on micronutrients and specialty fertilizers. While exact segment revenue percentages are not always explicitly reported with fine granularity, micronutrients remain the flagship product category. The company also has segments contributing smaller but growing portions of revenue:
Plant Protection: Includes pesticides, herbicides, and fungicides.
Animal Nutrition: Offers mineral feed supplements for livestock.
The company continually expands its product portfolio within these segments, with fertilizers (especially micronutrients) forming the dominant share.
Industry
The Indian fertilizer industry is characterized by its dependence on monsoons, government policies (subsidies, pricing, import regulations), and raw material price volatility. Aries Agro operates within the niche, but growing, specialty and micronutrient fertilizer segment, rather than the highly commoditized NPK (Nitrogen, Phosphorus, Potassium) segment dominated by larger public and private players. It holds a strong position as a pioneer and a leading player in the Indian micronutrient fertilizer market, differentiated by its R&D focus, wide product range, and established brand recognition among farmers for specific nutrient solutions. Its positioning allows it to cater to specific soil and crop needs, offering higher value products.
MOAT
Aries Agro possesses several competitive advantages:
Brand Recognition & Trust: As one of the earliest entrants and leaders in the micronutrient space in India, the "Aries" brand has built significant trust and recall among farmers for specific crop nutrition solutions.
Extensive Distribution Network: The company has a well-established and deep distribution network spanning across various states, ensuring last-mile connectivity to farmers in diverse agricultural regions.
Formulation Expertise & R&D: A focus on research and development allows them to develop specialized, high-efficacy products tailored for Indian soil conditions and crop requirements, creating a barrier for new entrants in complex formulations.
Product Portfolio Diversification: A broad portfolio of micronutrients, water-soluble fertilizers, plant protection, and animal nutrition products offers a comprehensive solution basket to farmers and mitigates risks associated with a single product category.
Growth Drivers
Increasing Awareness of Balanced Nutrition: Growing understanding among farmers about the importance of micronutrients for soil health, crop yield, and quality.
Government Initiatives: Policies promoting balanced fertilization, soil health cards, and reduction in the use of chemical fertilizers indirectly boost demand for specialty nutrients.
Diversification into New Product Categories: Expansion into plant protection, animal nutrition, and organic products provides new avenues for growth.
Climate Change & Soil Degradation: The need for specialized inputs to combat soil nutrient depletion and adapt to changing climatic patterns.
Market Penetration & Geographic Expansion: Deepening reach in existing markets and expanding into new agricultural geographies within India and potentially internationally.
Risks
Monsoon Dependency: The agricultural sector is heavily reliant on monsoon patterns; erratic or deficient rainfall can significantly impact demand for agri-inputs.
Raw Material Price Volatility: Fluctuations in the prices of key imported and domestic raw materials can impact production costs and profitability.
Regulatory & Policy Changes: Changes in government fertilizer policies, subsidies, pricing controls, or import duties can significantly affect the business.
Competition: Intense competition from larger domestic and international players, as well as unorganized sector players, particularly in more commoditized product segments.
Working Capital Management: The business is seasonal and requires significant working capital for inventory and managing receivables, particularly for subsidized products.
Pest & Disease Outbreaks: Unexpected outbreaks can lead to sudden shifts in demand for certain products and impact overall agricultural output.
Management & Ownership
Aries Agro Ltd. is a promoter-driven company, led by the Mirchandani family. Dr. Jimmy R. Mirchandani, the Chairman and Managing Director, has been instrumental in founding and scaling the company, bringing decades of experience in the agri-inputs sector. The management team generally comprises individuals with deep experience in agriculture, chemistry, and business administration. The promoter group holds a significant stake in the company, aligning their interests with long-term growth. This stable, experienced leadership provides continuity and strategic direction.
Outlook
Aries Agro benefits from its established leadership in India's growing micronutrient and specialty fertilizer market, driven by increasing farmer awareness and government emphasis on balanced nutrition. Its extensive distribution network and R&D capabilities provide a strong foundation for future growth, especially as it diversifies into related agri-inputs and animal nutrition. The demand for value-added agricultural inputs is likely to expand with evolving farming practices and soil health concerns. However, the company remains susceptible to the inherent risks of the Indian agricultural sector, including monsoon volatility, fluctuations in raw material prices, and potential changes in government policies regarding fertilizers. While its niche focus offers some insulation from bulk fertilizer commodity cycles, competition and effective working capital management in a seasonal business remain crucial for sustained profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 107 | 135 | 194 | 170 | 128 | 161 | 204 | 202 | 185 | 188 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 107 | 135 | 194 | 170 | 128 | 161 | 204 | 202 | 185 | 188 |
| Total Expenditure | 108 | 120 | 159 | 149 | 127 | 139 | 166 | 174 | 184 | 160 |
| Operating Profit | -1 | 15 | 34 | 22 | 1 | 22 | 38 | 29 | 0 | 27 |
| Interest | 5 | 3 | 8 | 5 | 3 | 5 | 8 | 2 | 3 | 5 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -8 | 11 | 24 | 15 | -5 | 14 | 28 | 24 | -6 | 20 |
| Provision for Tax | -2 | 3 | 5 | 3 | -1 | 5 | 8 | 7 | -1 | 5 |
| Profit After Tax | -6 | 7 | 19 | 11 | -4 | 10 | 20 | 17 | -5 | 15 |
| Adjustments | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | -6 | 7 | 19 | 12 | -4 | 10 | 20 | 17 | -4 | 15 |
| Adjusted Earnings Per Share | -4.3 | 5.6 | 14.5 | 8.9 | -2.8 | 7.7 | 15.4 | 13.3 | -3.4 | 11.5 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 263 | 253 | 291 | 265 | 296 | 381 | 432 | 472 | 516 | 622 | 740 | 779 |
| Other Income | 1 | 3 | 2 | 3 | 7 | 0 | 4 | 9 | 3 | 5 | 13 | 0 |
| Total Income | 264 | 256 | 293 | 269 | 303 | 382 | 436 | 481 | 519 | 627 | 753 | 779 |
| Total Expenditure | 217 | 214 | 245 | 222 | 256 | 325 | 386 | 424 | 461 | 555 | 664 | 684 |
| Operating Profit | 47 | 42 | 48 | 47 | 47 | 57 | 51 | 57 | 58 | 72 | 89 | 94 |
| Interest | 25 | 23 | 29 | 29 | 26 | 26 | 24 | 23 | 22 | 19 | 18 | 18 |
| Depreciation | 11 | 7 | 2 | 2 | 5 | 6 | 6 | 8 | 8 | 9 | 11 | 12 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 12 | 12 | 17 | 16 | 16 | 25 | 20 | 25 | 28 | 44 | 60 | 66 |
| Provision for Tax | 4 | 7 | 8 | 8 | 7 | 7 | 7 | 9 | 10 | 11 | 18 | 19 |
| Profit After Tax | 8 | 5 | 9 | 8 | 9 | 17 | 13 | 16 | 18 | 33 | 42 | 47 |
| Adjustments | -1 | 2 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 7 | 7 | 9 | 8 | 11 | 18 | 13 | 16 | 18 | 33 | 42 | 48 |
| Adjusted Earnings Per Share | 5.6 | 5.4 | 7 | 5.9 | 8.1 | 13.8 | 10.2 | 12.2 | 14.1 | 25.8 | 32.6 | 36.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 19% | 16% | 14% | 11% |
| Operating Profit CAGR | 24% | 16% | 9% | 7% |
| PAT CAGR | 27% | 38% | 20% | 18% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 27% | 39% | 27% | 15% |
| ROE Average | 14% | 11% | 9% | 7% |
| ROCE Average | 22% | 19% | 17% | 14% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 172 | 175 | 183 | 189 | 194 | 211 | 224 | 243 | 260 | 290 | 334 |
| Minority's Interest | 43 | 38 | 26 | 24 | 9 | 7 | 6 | 4 | 4 | 4 | 4 |
| Borrowings | 12 | 14 | 16 | 13 | 14 | 12 | 18 | 22 | 26 | 32 | 31 |
| Other Non-Current Liabilities | 6 | 6 | 6 | 6 | 11 | 12 | 10 | 13 | 14 | 20 | 23 |
| Total Current Liabilities | 216 | 217 | 246 | 262 | 258 | 259 | 251 | 238 | 213 | 235 | 247 |
| Total Liabilities | 448 | 450 | 477 | 494 | 487 | 501 | 509 | 520 | 517 | 581 | 639 |
| Fixed Assets | 87 | 71 | 88 | 95 | 48 | 55 | 68 | 75 | 96 | 110 | 116 |
| Other Non-Current Assets | 19 | 22 | 14 | 15 | 72 | 70 | 57 | 62 | 65 | 74 | 105 |
| Total Current Assets | 342 | 357 | 376 | 384 | 368 | 376 | 384 | 382 | 357 | 397 | 417 |
| Total Assets | 448 | 450 | 477 | 494 | 487 | 501 | 509 | 520 | 517 | 581 | 639 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 5 | 4 | 6 | 6 | 4 | 1 | 1 | 1 | 2 | 2 | 29 |
| Cash Flow from Operating Activities | 34 | 48 | 14 | 44 | 59 | 56 | 69 | 55 | 77 | 105 | 86 |
| Cash Flow from Investing Activities | -25 | 13 | -2 | -10 | -41 | -14 | -13 | -16 | -26 | -34 | -78 |
| Cash Flow from Financing Activities | -9 | -59 | -12 | -36 | -21 | -43 | -56 | -37 | -50 | -45 | -12 |
| Net Cash Inflow / Outflow | -0 | 2 | 0 | -2 | -4 | -0 | 0 | 1 | 1 | 26 | -4 |
| Closing Cash & Cash Equivalent | 4 | 6 | 6 | 4 | 1 | 1 | 1 | 2 | 2 | 29 | 25 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 5.56 | 5.43 | 6.99 | 5.92 | 8.14 | 13.81 | 10.22 | 12.25 | 14.15 | 25.76 | 32.58 |
| CEPS(Rs) | 14.42 | 9.33 | 8.73 | 7.78 | 10.77 | 18.16 | 14.4 | 18.28 | 20.1 | 32.93 | 40.93 |
| DPS(Rs) | 1.5 | 2 | 2.3 | 1.8 | 0.5 | 0.8 | 0.8 | 1 | 1 | 1.2 | 2.5 |
| Book NAV/Share(Rs) | 131.95 | 134.72 | 140.65 | 145.42 | 149.35 | 161.92 | 172.44 | 186.75 | 200.2 | 222.68 | 257.12 |
| Core EBITDA Margin(%) | 15.88 | 12.45 | 13.1 | 13.61 | 10.71 | 11.96 | 8.51 | 7.8 | 8.24 | 8.41 | 7.96 |
| EBIT Margin(%) | 12.72 | 11.29 | 13.02 | 13.89 | 11.21 | 10.66 | 8.17 | 7.97 | 7.53 | 7.83 | 8.15 |
| Pre Tax Margin(%) | 4.2 | 3.82 | 4.77 | 4.85 | 4.34 | 5.19 | 3.7 | 4.14 | 4.22 | 5.52 | 6.3 |
| PAT Margin (%) | 2.82 | 1.74 | 2.6 | 2.4 | 2.33 | 3.62 | 2.36 | 2.6 | 2.73 | 4.16 | 4.43 |
| Cash Profit Margin (%) | 6.47 | 3.88 | 3.24 | 3.16 | 3.77 | 4.98 | 3.42 | 3.88 | 3.88 | 5.32 | 5.56 |
| ROA(%) | 1.83 | 1.21 | 1.96 | 1.59 | 1.76 | 3.48 | 2.56 | 3.1 | 3.55 | 6.1 | 6.94 |
| ROE(%) | 4.67 | 3.14 | 5.08 | 4.14 | 4.51 | 8.48 | 5.95 | 6.82 | 7.31 | 12.18 | 13.58 |
| ROCE(%) | 10.79 | 10.85 | 13.69 | 12.45 | 11.81 | 14.67 | 13.26 | 14.59 | 15.15 | 18.95 | 21.7 |
| Receivable days | 157.25 | 152.06 | 169.18 | 209.71 | 148.44 | 92.06 | 80.43 | 70.56 | 62.79 | 52.38 | 40.05 |
| Inventory Days | 180.83 | 165.58 | 140.04 | 146.39 | 131.57 | 107.22 | 95.84 | 86.72 | 73.31 | 58.8 | 52.78 |
| Payable days | 114.65 | 116.89 | 132.52 | 209.93 | 193.67 | 119.6 | 108.98 | 108.14 | 85.28 | 63.32 | 63.09 |
| PER(x) | 16.2 | 28.49 | 25.22 | 14.65 | 4.91 | 5.6 | 13.37 | 12.08 | 17.11 | 9.82 | 9.95 |
| Price/Book(x) | 0.68 | 1.15 | 1.25 | 0.6 | 0.27 | 0.48 | 0.79 | 0.79 | 1.21 | 1.14 | 1.26 |
| Dividend Yield(%) | 1.66 | 1.29 | 1.3 | 2.07 | 1.25 | 1.03 | 0.59 | 0.68 | 0.41 | 0.47 | 0.77 |
| EV/Net Sales(x) | 1.04 | 1.3 | 1.34 | 1.04 | 0.67 | 0.61 | 0.65 | 0.6 | 0.73 | 0.55 | 0.6 |
| EV/Core EBITDA(x) | 5.79 | 7.8 | 8.14 | 5.88 | 4.21 | 4.05 | 5.55 | 5 | 6.49 | 4.71 | 4.98 |
| Net Sales Growth(%) | -13.79 | -3.9 | 15.36 | -8.92 | 11.62 | 28.81 | 13.34 | 9.22 | 9.36 | 20.52 | 18.9 |
| EBIT Growth(%) | -20.95 | -4.15 | 29.11 | -2.44 | -6.36 | 21.42 | -11.47 | 8.92 | 3.9 | 24.24 | 23.91 |
| PAT Growth(%) | -57.47 | -33.29 | 66.79 | -15.28 | 12.23 | 98.72 | -24.62 | 23.07 | 15.51 | 82.04 | 26.5 |
| EPS Growth(%) | -57.12 | -2.35 | 28.72 | -15.28 | 37.48 | 69.64 | -25.99 | 19.86 | 15.51 | 82.04 | 26.5 |
| Debt/Equity(x) | 0.97 | 0.78 | 0.93 | 0.91 | 0.77 | 0.64 | 0.47 | 0.39 | 0.27 | 0.15 | 0.15 |
| Current Ratio(x) | 1.58 | 1.65 | 1.53 | 1.47 | 1.42 | 1.45 | 1.53 | 1.61 | 1.68 | 1.69 | 1.69 |
| Quick Ratio(x) | 0.92 | 0.99 | 1.01 | 0.97 | 0.89 | 0.91 | 0.94 | 1 | 1.08 | 1.12 | 1.11 |
| Interest Cover(x) | 1.49 | 1.51 | 1.58 | 1.54 | 1.63 | 1.95 | 1.83 | 2.08 | 2.27 | 3.39 | 4.4 |
| Total Debt/Mcap(x) | 1.42 | 0.68 | 0.75 | 1.52 | 2.89 | 1.34 | 0.6 | 0.5 | 0.22 | 0.13 | 0.12 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 |
| FII | 3.29 | 3.08 | 2.53 | 3.38 | 2.98 | 4.29 | 3.2 | 2.91 | 3.25 | 3.13 |
| DII | 0 | 0 | 0 | 0 | 0 | 0.26 | 0 | 0 | 0 | 0.02 |
| Public | 44.05 | 44.26 | 44.81 | 43.96 | 44.36 | 42.79 | 44.14 | 44.43 | 44.09 | 44.19 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 |
| FII | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.57 | 0.58 | 0.58 | 0.57 | 0.58 | 0.56 | 0.57 | 0.58 | 0.57 | 0.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +19% | +16% | +14% | +11% |
| Operating Profit CAGR | +24% | +16% | +9% | +7% |
| PAT CAGR | +27% | +38% | +20% | +18% |
| Share Price CAGR | +27% | +39% | +27% | +15% |
| ROE Average | +14% | +11% | +9% | +7% |
| ROCE Average | +22% | +19% | +17% | +14% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 |
| FII | 3.29 | 3.08 | 2.53 | 3.38 | 2.98 | 4.29 | 3.2 | 2.91 | 3.25 | 3.13 |
| DII | 0 | 0 | 0 | 0 | 0 | 0.26 | 0 | 0 | 0 | 0.02 |
| Public | 44.05 | 44.26 | 44.81 | 43.96 | 44.36 | 42.79 | 44.14 | 44.43 | 44.09 | 44.19 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 |
| FII | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.57 | 0.58 | 0.58 | 0.57 | 0.58 | 0.56 | 0.57 | 0.58 | 0.57 | 0.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.